Literature DB >> 32449936

CVCDAP: an integrated platform for molecular and clinical analysis of cancer virtual cohorts.

Xiaoqing Guan1,2, Meng Cai3, Yang Du1, Ence Yang3, Jiafu Ji2, Jianmin Wu1,4.   

Abstract

Recent large-scale multi-omics studies resulted in quick accumulation of an overwhelming amount of cancer-related data, which provides an unprecedented resource to interrogate diverse questions. While certain existing web servers are valuable and widely used, analysis and visualization functions with regard to re-investigation of these data at cohort level are not adequately addressed. Here, we present CVCDAP, a web-based platform to deliver an interactive and customizable toolbox off the shelf for cohort-level analysis of TCGA and CPTAC public datasets, as well as user uploaded datasets. CVCDAP allows flexible selection of patients sharing common molecular and/or clinical characteristics across multiple studies as a virtual cohort, and provides dozens of built-in customizable tools for seamless genomic, transcriptomic, proteomic and clinical analysis of a single virtual cohort, as well as, to compare two virtual cohorts with relevance. The flexibility and analytic competence of CVCDAP empower experimental and clinical researchers to identify new molecular mechanisms and develop potential therapeutic approaches, by building and analyzing virtual cohorts for their subject of interests. We demonstrate that CVCDAP can conveniently reproduce published findings and reveal novel insights by two applications. The CVCDAP web server is freely available at https://omics.bjcancer.org/cvcdap/.
© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Year:  2020        PMID: 32449936     DOI: 10.1093/nar/gkaa423

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  9 in total

1.  A network approach reveals driver genes associated with survival of patients with triple-negative breast cancer.

Authors:  Courtney D Dill; Eric B Dammer; Ti'ara L Griffen; Nicholas T Seyfried; James W Lillard
Journal:  iScience       Date:  2021-04-19

2.  PODNL1 Methylation Serves as a Prognostic Biomarker and Associates with Immune Cell Infiltration and Immune Checkpoint Blockade Response in Lower-Grade Glioma.

Authors:  Humaira Noor; Ashraf Zaman; Charles Teo; Michael E Sughrue
Journal:  Int J Mol Sci       Date:  2021-11-22       Impact factor: 5.923

3.  Copy Number Variation of Circulating Tumor DNA (ctDNA) Detected Using NIPT in Neoadjuvant Chemotherapy-Treated Ovarian Cancer Patients.

Authors:  Mina Sharbatoghli; Fahimeh Fattahi; Hamidreza Aboulkheyr Es; Arvand Akbari; Setareh Akhavan; Marzieh Ebrahimi; Mohsen Asadi-Lari; Mehdi Totonchi; Zahra Madjd
Journal:  Front Genet       Date:  2022-07-22       Impact factor: 4.772

4.  Sex differences in hepatocellular carcinoma indicated BEX4 as a potential target to improve efficacy of lenvatinib plus immune checkpoint inhibitors.

Authors:  Lu Liu; Kangkang Yu; Chong Huang; Meisi Huo; Xiaoqi Li; Ruiqi Yin; Chuanmiao Liu; Lu Lu; Huaping Sun; Jubo Zhang
Journal:  J Cancer       Date:  2022-09-06       Impact factor: 4.478

5.  Virtual Cohorts and Synthetic Data in Dementia: An Illustration of Their Potential to Advance Research.

Authors:  Graciela Muniz-Terrera; Ofer Mendelevitch; Rodrigo Barnes; Michael D Lesh
Journal:  Front Artif Intell       Date:  2021-05-17

6.  UCSCXenaShiny: An R/CRAN Package for Interactive Analysis of UCSC Xena Data.

Authors:  Shixiang Wang; Yi Xiong; Longfei Zhao; Kai Gu; Yin Li; Fei Zhao; Jianfeng Li; Mingjie Wang; Haitao Wang; Ziyu Tao; Tao Wu; Yichao Zheng; Xuejun Li; Xue-Song Liu
Journal:  Bioinformatics       Date:  2021-07-29       Impact factor: 6.937

7.  Analyzing the key gene expression and prognostics values for acute myeloid leukemia.

Authors:  Lingling Shi; Yan Huang; Xunjun Huang; Weijie Zhou; Jie Wei; Donghong Deng; Yongrong Lai
Journal:  Transl Cancer Res       Date:  2020-11       Impact factor: 1.241

8.  Integrative Analysis of MUC4 to Prognosis and Immune Infiltration in Pan-Cancer: Friend or Foe?

Authors:  Xiao-Peng Gao; Jie-Jie Dong; Tian Xie; Xiaoqing Guan
Journal:  Front Cell Dev Biol       Date:  2021-07-16

9.  Targeting E2 ubiquitin-conjugating enzyme UbcH5c by small molecule inhibitor suppresses pancreatic cancer growth and metastasis.

Authors:  Simin Qi; Xiaoqing Guan; Jia Zhang; Dehua Yu; Xuefei Yu; Qinglin Li; Wenjuan Yin; Xiang-Dong Cheng; Weidong Zhang; Jiang-Jiang Qin
Journal:  Mol Cancer       Date:  2022-03-10       Impact factor: 27.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.